Xue Chen Li
Director/Board Member chez YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD.
Fortune : 5 561 $ au 31/03/2024
Profil
Xue Chen Li is an Independent Non-Executive Director at YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
and a Director at HEC Pharm Co., Ltd.
He holds a doctorate degree from Harvard University, a graduate degree from the University of Alberta, and an undergraduate degree from Nankai University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2023 | 4 000 ( 0,00% ) | 5 561 $ | 31/03/2024 |
Postes actifs de Xue Chen Li
| Sociétés | Poste | Début |
|---|---|---|
| YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. | Director/Board Member | 25/09/2020 |
HEC Pharm Co., Ltd.
 HEC Pharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Yichang Dongyang Changjiang Pharmaceuical Co. Ltd. manufactures pharmaceutical products. The Company mainly develops, produces, and distributes active pharmaceutical ingredients and insulins. The firm focuses on anti-virus, endocrine and metabolic diseases and cardiovascular diseases. The company was founded on August 08, 2001and is headquartered in Dongguan, China. | Director/Board Member | - |
Formation de Xue Chen Li
| Harvard University | Doctorate Degree |
| University of Alberta | Graduate Degree |
| Nankai University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| YICHANG HEC CHANGJIANG PHARMACEUTICAL CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
HEC Pharm Co., Ltd.
HEC Pharm Co., Ltd. Pharmaceuticals: MajorHealth Technology Yichang Dongyang Changjiang Pharmaceuical Co. Ltd. manufactures pharmaceutical products. The Company mainly develops, produces, and distributes active pharmaceutical ingredients and insulins. The firm focuses on anti-virus, endocrine and metabolic diseases and cardiovascular diseases. The company was founded on August 08, 2001and is headquartered in Dongguan, China. | Health Technology |
